What is the appropriate vitamin B12 (cyanocobalamin) injection regimen for a 32 kg patient to correct deficiency?

Vitamin B12 Injection Dosing for 32 kg Patient

For a 32 kg patient with vitamin B12 deficiency, administer hydroxocobalamin 1 mg intramuscularly three times weekly for 2 weeks if there are no neurological symptoms, followed by 1 mg intramuscularly every 2-3 months for lifelong maintenance. 1

Critical First Step: Assess for Neurological Involvement

Before initiating treatment, you must determine whether neurological symptoms are present, as this fundamentally changes the treatment regimen:

Look for these specific neurological signs:

• Unexplained sensory symptoms (numbness, tingling, paresthesias)
• Motor symptoms (weakness, difficulty walking)
• Gait disturbances or ataxia
• Cognitive changes (memory loss, impaired concentration)
• Loss of vibration sense

If ANY neurological symptoms are present, seek urgent specialist advice from neurology and hematology immediately 1.

Treatment Algorithm Based on Neurological Status

WITH Neurological Involvement

• Loading phase: Hydroxocobalamin 1 mg IM on alternate days until no further improvement occurs
• Maintenance: Hydroxocobalamin 1 mg IM every 2 months lifelong 1

WITHOUT Neurological Involvement (Most Common)

• Loading phase: Hydroxocobalamin 1 mg IM three times weekly for 2 weeks (total of 6 doses)
• Maintenance: Hydroxocobalamin 1 mg IM every 2-3 months lifelong 1

Key Clinical Considerations

Body weight does NOT affect dosing. The 1 mg dose is standard for all patients regardless of weight, as vitamin B12 dosing is not weight-based in clinical practice 1. The pediatric guideline confirms 1 mcg/day for children over 12 months, but for deficiency correction (not maintenance), the adult 1 mg IM protocol applies 2.

Critical safety warning: Do NOT give folic acid before or simultaneously with initial B12 treatment, as this can mask B12 deficiency and precipitate subacute combined degeneration of the spinal cord—a devastating and potentially irreversible neurological complication 1.

Why These Specific Doses?

The 1 mg (1000 mcg) intramuscular dose is recommended because:

• Much greater amounts of B12 are retained with 1000 mcg injection compared to 100 mcg 3
• This dose ensures adequate tissue saturation and metabolic requirements are met
• No disadvantage in cost or toxicity with the higher dose 3
• The dose bypasses the absorption issues that caused the deficiency

Common Pitfalls to Avoid

1. Don't reduce frequency too quickly: Some patients require more frequent maintenance dosing (every 4-6 weeks rather than every 2-3 months) to remain symptom-free. If symptoms recur, increase injection frequency rather than measuring serum B12 levels to guide dosing 4.

2. Don't use serum B12 levels to titrate maintenance therapy: Clinical response, not laboratory values, should guide ongoing treatment frequency 4.

3. Don't assume oral supplementation is equivalent: While recent evidence suggests high-dose oral B12 (1000-2000 mcg daily) may work in some deficiency cases 5, 6, intramuscular therapy remains the gold standard for malabsorption-related deficiency and produces more rapid improvement, particularly when neurological symptoms are present 7.

4. Don't forget lifelong treatment: Most causes of B12 deficiency requiring injection therapy are permanent conditions requiring indefinite maintenance 1.

Monitoring Response

Expect reticulocytosis (indicating bone marrow response) between days 5-10 of treatment 5. Neurological improvement, when present, typically occurs within 30 days in approximately 75-80% of patients 5.